Recent Finacing
Recent Raise
CureVac develops mRNA-based vaccines, cancer immunotherapies and mRNA-encoded therapeutics via proprietary RNA platforms for protein design, optimization and delivery, with clinical programs and production sites in Germany and Boston.
